Apotex Suffers Defeat In Acular Dispute
Judge Martin J. Jenkins of the U.S. District Court for the Northern District of California on Tuesday granted summary judgment in favor of plaintiffs Roche and Allergan, finding that Apotex’s abbreviated new drug application (ANDA) violated the Acular patent, and that the patent was valid...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login